A prospective, double-blind, randomised, placebo controlled, crossover trial of azithromycin in paediatric cystic fibrosis

被引：0
|
作者：
Equi, A [1 ]
Bush, A [1 ]
Balfour-Lynn, IM [1 ]
Rosenthal, M [1 ]
机构：
[1] Royal Brompton & Harefield NHS Trust, London, England
来源：
THORAX | 2002年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S125
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
    Wong, Conroy
    Jayaram, Lata
    Karalus, Noel
    Eaton, Tam
    Tong, Cecilia
    Hockey, Hans
    Milne, David
    Fergusson, Wendy
    Tuffery, Christine
    Sexton, Paul
    Storey, Louanne
    Ashton, Toni
    LANCET, 2012, 380 (9842): : 660 - 667
  • [2] Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
    Equi, A
    Balfour-Lynn, IM
    Bush, A
    Rosenthal, M
    LANCET, 2002, 360 (9338): : 978 - 984
  • [3] Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial
    Clement, A.
    Tamalet, A.
    Leroux, E.
    Ravilly, S.
    Fauroux, B.
    Jais, J-P
    THORAX, 2006, 61 (10) : 895 - 902
  • [4] A DOUBLE-BLIND CROSSOVER PLACEBO CONTROLLED TRIAL OF XIMOPROFEN IN AS
    DOUGADOS, M
    CAPORAL, R
    DOURY, P
    THIESCE, A
    PATTIN, S
    LAFFEZ, B
    AMOR, B
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (08) : 1167 - 1169
  • [5] Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial
    Evans, AT
    Husain, S
    Durairaj, L
    Sadowski, LS
    Charles-Damte, M
    Wang, Y
    LANCET, 2002, 359 (9318): : 1648 - 1654
  • [6] The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial
    Stick, Stephen M.
    Foti, Alexia
    Ware, Robert S.
    Tiddens, Harm A. W. M.
    Clements, Barry S.
    Armstrong, David S.
    Selvadurai, Hiran
    Tai, Andrew
    Cooper, Peter J.
    Byrnes, Catherine A.
    Belessis, Yvonne
    Wainwright, Claire
    Jaffe, Adam
    Robinson, Philip
    Saiman, Lisa
    Sly, Peter D.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (08): : 776 - 784
  • [7] Once weekly azithromycin in cystic fibrosis:: A double-blind, randomised trial in patients with chronic Pseudomonas aeruginosa infection
    Steinkamp, G.
    Schmitt-Grohe, S.
    Doering, G.
    Staab, D.
    Schubert, R.
    Zielen, S.
    PEDIATRIC PULMONOLOGY, 2007, : 300 - 300
  • [8] Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial
    Gelderblom, Harald
    Wuestenberg, Torsten
    McLean, Tim
    Muetze, Lisanne
    Fischer, Wilhelm
    Saft, Carsten
    Hoffmann, Rainer
    Suessmuth, Sigurd
    Schlattmann, Peter
    van Duijn, Erik
    Landwehrmeyer, Bernhard
    Priller, Josef
    PLOS ONE, 2017, 12 (03):
  • [9] A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis
    Epifanio, Matias
    Marostica, Paulo C.
    Mattiello, Rita
    Feix, Larissa
    Nejedlo, Regina
    Fischer, Gilberto B.
    Stein, Renato T.
    JORNAL DE PEDIATRIA, 2012, 88 (02) : 155 - 160
  • [10] Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
    Ratjen, Felix
    Davis, Stephanie D.
    Stanojevic, Sanja
    Kronmal, Richard A.
    Stukovsky, Karen D. Hinckley
    Jorgensen, Neal
    Rosenfeld, Margaret
    LANCET RESPIRATORY MEDICINE, 2019, 7 (09): : 802 - 809
12345